Comment and reply on: Serum chemerin and vaspin in non-alcoholic fatty liver disease

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 7-8, 2010, Pages 1000-1002

  Dogru, Teoman ^a   Karadurmus, Nuri ^b   Tapan, Serkan ^b   Genc, Halil ^a  

^a Department of Gastroenterology ^*  (Australia)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CHEMERIN; GLUCOSE; INSULIN; UNCLASSIFIED DRUG; VASPIN;

BLOOD LEVEL; BODY MASS; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 77955677373     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521003749826     Document Type: Letter

References (9)

1. Kukla M, Zwrska-Korczala K, Hartleb M, Waluga M, Chwist A, Kajor M, et al. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010;45:235-242
2. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148:4687-4694
3. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 2009;161:339-344
4. Seeger J, Ziegelmeier M, Bachmann A, Lössner U, Kratcszh J, Blüher M, Stumvoll M, Fasshauer M. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008;93:247-251
5. Yun JW, Cho YK, Park JH, Kim HJ, Park DL, Sohn CL, Jeon WK, Kim BL. Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. Liver nt 2009;29:525-529
6. Takahashi M, Takahashi Y, Takahashi K, Zolatoryov FN, Hong KS, Kitazawa R, et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett 2008;582:573-578
7. Klöting N, Berndt J, Kralisch S, Kovasc P, Fasshauer M, Schön MR, Stumvoll M, Blüher M. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006;339: 430-436
8. Tan BK, Chen J, Farhatullah S, Adya R, Kaur J, Heutling D, et al. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009;58:1971-1977
9. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008;57:1501-1507